GlassScriptPhysician profile
Kimberly Mcgill
NPI 1285839803
$1,482.98
in general payments reported to CMS, 2019-2025
23 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2020: $247 · 2023: $169 · 2024: $250 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.50 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $335.89 | 2019-2023 | |
| Davol INC. | $218.29 | 2020 | |
| Biogen, INC. | $153.46 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $123.49 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $110.44 | 2023-2025 | |
| Exeltis, USA INC. | $76.48 | 2023-2025 | Slynd |
| Evofem Biosciences, INC. | $55.04 | 2024-2025 | Solosec, Phexx, Phexxi |
| Bayer Healthcare Pharmaceuticals INC. | $51.73 | 2019-2025 | |
| Pfizer INC. | $47.71 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $39.74 | 2024-2025 | Myfembree, Gemtesa |
| Therapeuticsmd, INC. | $36.24 | 2019-2020 | |
| Dexcom, INC. | $35.66 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $27.56 | 2019 | |
| Amag Pharmaceuticals, INC. | $23.49 | 2019 | |
| Aspira Women'S Health INC | $22.82 | 2024 | Ova1 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $22.47 | 2024 | |
| Daiichi Sankyo INC. | $17.17 | 2019 | |
| Hologic Sales and Service, LLC | $16.42 | 2025 | Acessa Provu System, Novasure |
| Exact Sciences Corporation | $16.22 | 2024 | Cologuard Collection Kit |
| Minerva Surgical, INC | $14.63 | 2023 | |
| Lupin INC. | $13.45 | 2019 | |
| Duchesnay USA Incorporated | $13.22 | 2019 | |
| Coopersurgical, INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Mcgill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.